Authors:
GALLAGHER M
ALLEN SL
STEVENSON J
HILLER K
OMARA V
VELAGAPUDI R
MITCHELL E
VILLALONA M
VANECHO D
JAKIMOWICZ K
ALLEN LF
FISCHKOFF S
ODWYER PJ
Citation: M. Gallagher et al., PHASE-I TRIAL OF THE DOLASTATIN-15 ANALOG LU-103793 (CEMADOTIN) EVERYOTHER DAY FOR 3 DOSES, Annals of oncology, 9, 1998, pp. 386-386
Authors:
LICHTMAN SM
CASACELLA P
BUDMAN DR
WILLIAMS G
EISENBERG P
DAMICO P
OMARA V
MUSGRAVE K
ETCUBANAS E
Citation: Sm. Lichtman et al., DEVELOPMENT OF A FLUDARABINE PHOSPHATE (FAMP) DOSING FORMULA IN PATIENTS WITH RENAL-INSUFFICIENCY BASED ON A PHARMACOKINETIC (PK) STUDY IN PATIENTS WITH AND WITHOUT RENAL IMPAIRMENT, British Journal of Haematology, 102(1), 1998, pp. 245-245
Citation: Dr. Budman et al., SEVERE NEUROTOXICITY IN VINORELBINE-PACLITAXEL COMBINATIONS, Journal of the National Cancer Institute, 89(1), 1997, pp. 87-88
Authors:
KOLITZ JE
OMARA V
WILLEMZE R
POYNTON CH
JAEGER U
BRODY J
SCHULMAN P
Citation: Je. Kolitz et al., TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITH CAMPATH-1H - INITIAL OBSERVATIONS, Blood, 84(10), 1994, pp. 10000301-10000301